SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
Nurix Therapeutics, Inc.
@NRIX_InsiderForm 4 Filing: Hansen Gwenn Sells $89,953.632 of $NRIX
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Nurix Therapeutics, Inc.
Ticker: $NRIX
Transaction Value
$89,953.632
Price/Share: $6.41
transaction date
2026-07-30
Shares: 14,027
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hansen Gwenn, holds the title of Chief Scientific Officer at Nurix Therapeutics, Inc..
On 2026-07-30, the insider transacted 14,027 shares.The shares were transacted at a weighted average price of $6.41 per share, resulting in a total market-relevant value of $89,953.632.
Executive Summary Summary
Hansen Gwenn (Chief Scientific Officer) sold $90K of $NRIX
Post-Transaction Position: 121,338 shares
SEC Accession No: 0001817160-26-000012 (CIK: 1817160)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.